CAR-T Referral Process: Insights from UCSF : Episode 4
Referral Process for CAR T-Cell Therapy: Initial Contact Through Patient Evaluation and Selection
Panelists discuss how the typical CAR T-cell therapy referral process begins with community physicians contacting the treatment center. The patient undergoes a thorough evaluation, including medical history, eligibility criteria, and pretreatment assessments before final selection for therapy.
Video content above is prompted by the following:
- Walk us through the typical CAR T referral process at your institution––from the initial community physician outreach to the patient evaluation and selection.
Recent Videos
Related Content
Considering NCCN Guidelines to Determine Maintenance Therapy Multiple Myeloma
February 15th 2025Article
During the 66th American Society of Hematology Annual Meeting and Exposition, experts in multiple myeloma gathered to discuss the impact of maintenance therapy and minimal residual disease (MRD) in patients with newly diagnosed transplant-eligible or -ineligible multiple myeloma.
